Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study.

Maria Gabriela SuarezMadeleine StackJose Miguel Hinojosa-AmayaMichael D MitchellElena V VarlamovChris G YedinakJustin S CetasBrett SheppardMaria Fleseriu

Published in: Journal of the Endocrine Society (2019)

The risk of TEs in patients with CS was approximately 20%. Many patients had more than 1 event, with higher risk 30 to 60 days postoperatively. The optimal prophylactic anticoagulation duration is unknown, but most likely needs to continue up to 60 days postoperatively, particularly after BLA.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
venous thromboembolism
peritoneal dialysis
risk factors
atrial fibrillation
case report